Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
Aaron, abandonment, absent, accomplished, Aduracil, aggressive, agonist, Alexion, AmbioPharm, analyze, Anderson, Antitrust, Apax, Apovia, apparent, appeal, APT, arm, arose, Asian, aspect, assignee, assortment, AstraZeneca, attached, attorney, atypical, AU, Avastin, Avon, BA, Babson, BBA, beta, biography, Biolipox, BioNJ, Biosyn, bladder, breast, Burn, calcium, CAM, Camptosar, capecitabine, CAPM, cautionary, cautioned, CeaVac, Celltech, central, chain, Chairperson, chemotherapy, chorionic, CLDX, clearance, COBRA, colorectal, commensurate, concurrent, consecutive, consumption, contemplate, contemplated, Corixa, corroborated, CT, customary, dataset, default, Dendreon, dendritic, deposit, dermal, destroy, developmental, diagnosed, diagnosing, Diamond, disagree, disclaim, disclaimed, displaying, downstream, Duke, Durham, eb, EGFR, EGFRvIII, Electric, eleven, Eloxatin, emphasized, encouraged, energy, Eniluracil, epidermal, epithelial, EPS, Erbitux, ESPP, Evolution, executory, exert, expansion, exploit, exploited, explore, expressly, fact, faith, fast, fastest, Fca, FcaRI, Fordham, fractional, France, FSP, fusion, GBM, GBP, Genentech, Genitope, GenPharm, Georgetown, Germany, glioblastoma, glioma, gonadotropin, Grand, Haven, headcount, Hemolytic, HepVax, Herceptin, HHMI, hierarchy, Hoffmann, host, Houston, Howard, ID, identical, Idera, ImClone, Immunex, Incidence, Inland, innate, instruct, intent, intention, interfering, irinotecan, irrevocable, Japan, JD, Jefferson, Jewish, John, Johnson, jurisdiction, Kingdom, La, largest, Leucovorin, leukemic, linked, LLM, local, Ludwig, lymphoma, malignant, mammalian, mannose, Maxygen, median, mediate, mediated, melanoma, merged, metastatic, mice, minimal, minimize, modulation, monoclonal, monotherapy, multiforme, Museum, neck, NeoPharm, ninety, nonexclusive, nonforfeitable, nonprofit, Northwest, Notch, Omnicare, oncogene, Optherion, orderly, orphan, ovarian, oversaw, oxaliplatin, pancreatic, parent, particle, path, pattern, PCT, peer, perpetual, Pharmasset, Phillipsburg, Physiology, portrayal, precision, Princeton, pronouncement, proportionately, prostate, quantity, quoted, randomized, rare, ratified, rationale, reactogenicity, readily, recovery, recurring, reddening, reformulate, regimen, region, regional, regression, remove, removed, resiquimod, retreatment, Robert, Rockefeller, route, Schein, seroconversion, settlement, signaling, solid, sooner, Southampton, speak, splice, spouse, Squibb, staffing, standalone, stipend, subgroup, Supplementary, supplemented, survival, surviving, Symphony, Syndrome, temozolomide, Thailand, tie, Titan, TJU, TLR, TMZ, Tomudex, track, traditional, traditionally, transforming, transpire, travel, Treaty, tumor, twenty, UltiMAb, undergraduate, underwent, undiscounted, undue, unmet, unobservable, Unregistered, unregulated, untapped, Uremic, variant, vendor, VICTORI, VIII, Virginia, virtue, VTI, weekly, white, withdrew, WW, Xeloda, York
Removed:
accelerate, activated, adhesion, adjuvanted, afflicted, affordable, aged, allergic, anthrax, APB, Asia, assembled, attack, augment, bacteria, balloon, bank, billion, binding, biodefense, Biostability, bird, blended, boost, born, breeder, bridging, broadly, broiler, Bulletin, cabinet, calculated, California, capture, carbohydrate, cardiac, cardiopulmonary, cardiovascular, cerebral, chicken, clean, collaborated, comparing, conditioned, configuration, confirmed, confirming, contact, Cooke, cooperative, coupled, CPB, creditable, cut, decline, define, delivering, diarrheal, Diego, diet, disbursement, disqualifying, DNA, dosing, double, drying, DVC, dynport, dysentery, ease, EDD, elevate, elicit, eliminating, endothelial, endpoint, engineering, eventually, examine, execution, exercised, exhibited, favorable, fed, female, Finally, flexibility, formulated, franchise, frequent, gel, gene, generation, hatchery, HDL, heart, hen, hospitalized, ideal, immunized, improved, improving, infant, infarction, inhibition, institutional, intermediary, intubation, involvement, Iomai, ischemic, isolated, Keilani, law, lay, layer, LDL, licensure, lipoprotein, live, load, lowering, Maine, male, marriage, Marsh, MBL, measurable, medication, mid, mild, military, moderate, Modern, monetization, morbidity, mortality, moving, myocardial, nineteen, noncancelable, object, onset, organism, paragraph, participated, partly, partnered, partnering, Pasteur, pediatric, Pharmacia, pharmacologic, placement, plague, plant, posed, premium, prevalent, processing, prolonged, promise, published, pumping, reaction, real, realization, recombinantly, reducing, refrigeration, reliably, remitted, rendering, reperfusion, repurchase, repurchased, requisite, resold, respond, responded, rest, restriction, Riverview, room, safer, salmonella, SalmoVec, San, Sanofi, seed, selectin, shower, sialyl, significance, sLex, societal, solve, spp, spray, stability, statistical, step, stop, storage, stroke, subcontract, suggested, summarize, surgery, Taha, TC, temperature, thermostability, Timothy, titer, Today, transferred, transition, transplant, treasury, unconditional, understand, unique, unlocking, untreated, UPT, VaxGen, vector, vessel, virulent, VitriLife, vitro, VRI, warrant, Western, widely, yielding, younger, Zealand
Filing tables
Filing exhibits
Related press release
CLDX similar filings
Filing view
External links
QuickLinks -- Click here to rapidly navigate through this document
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (File Nos. 333-151728 and 333-117602) and on Form S-3 (File No. 333-143112) of Celldex Therapeutics, Inc. (formerly known as AVANT Immunotherapeutics, Inc.) of our report dated March 2, 2009 relating to the financial statements and the effectiveness of internal control over financial reporting, which appears in this Form 10-K.
/s/ PricewaterhouseCoopers LLP
Boston, Massachusetts
March 2, 2009
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM